- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03365102
Modulating Impulsivity in Suicidal Adolescents With Transcranial Direct Current Stimulation (tDCS) (tDCS)
5 de enero de 2022 actualizado por: Richard Liu, Lifespan
Modulating Impulsivity in Suicidal Adolescents With tDCS: A Proof of Concept Study
As a first step toward investigating whether modulation of impulsivity and associated neural pathways may yield clinically meaningful changes in risk for adolescent suicidal behavior, the R21 is a proof-of concept study evaluating the potential for tDCS targeting brain regions associated with behavioral impulsivity (right inferior frontal gyrus [rIFG]) and cognitive impulsivity (left orbitofrontal cortex [lOFC]) to modulate these facets of impulsivity in a sample of adolescent suicide attempters.
Participants will be randomly assigned to receive anodal tDCS over the rIFG, anodal tDCS over the lOFC, or a sham stimulation condition, in a three-group design.
Task-based measures of behavioral and cognitive impulsivity will be administered before and after tDCS or sham stimulation.
Additionally, electroencephalography (EEG) and event-related potential (ERP) data will be collected during the impulsivity tasks, and resting-state EEG data will be collected pre- and post-tDCS administration to confirm engagement of the targeted brain regions and to delineating the neural pathways underlying the effects of tDCS on impulsivity.
Descripción general del estudio
Estado
Terminado
Condiciones
Descripción detallada
Suicide is one of the leading causes of death in adolescence.
To improve the ability to predict and prevent suicidal behavior, there is a pressing need for research in this area to advance beyond identifying risk factors toward a greater focus on the mechanisms of risk for this behavior.
In particular, elucidating the neural pathways underlying risk for suicidal behavior is important insofar as such work may yield specific and modifiable targets for clinical intervention.
The adoption of new experimental paradigms providing experimental control over potentially modifiable risk factors has been recommended as a means of meaningfully advancing the field in this regard.
Although yet to be applied to the study of suicidality, transcranial direct current stimulation (tDCS), in conjunction with measures of electroencephalography (EEG) and event-related potentials (ERPs), may hold promise as an experimental paradigm in the study of potentially modifiable risk factors, and underlying neural mechanisms, for suicidality.
One such risk factor of particular relevance to suicide in adolescence is state-sensitive aspects of impulsivity.
Impulsivity has been consistently linked with suicidality, with this association appearing to be stronger in adolescence than adulthood.
As a first step toward investigating whether modulation of impulsivity and associated neural pathways may yield clinically meaningful changes in risk for adolescent suicidal behavior, the R21 is a proof-of concept study evaluating the potential for tDCS targeting brain regions associated with behavioral impulsivity (right inferior frontal gyrus [rIFG]) and cognitive impulsivity (left orbitofrontal cortex [lOFC]) to modulate these facets of impulsivity in a sample of adolescent suicide attempters.
Participants will be randomly assigned to receive anodal tDCS over the rIFG, anodal tDCS over the lOFC, or a sham stimulation condition, in a three-group design.
Task-based measures of behavioral and cognitive impulsivity will be administered before and after tDCS or sham stimulation.
Additionally, EEG and ERP data will be collected during the impulsivity tasks, and resting-state EEG data will be collected pre- and post-tDCS administration to confirm engagement of the targeted brain regions and to delineating the neural pathways underlying the effects of tDCS on impulsivity.
Tipo de estudio
Intervencionista
Inscripción (Actual)
64
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Rhode Island
-
Riverside, Rhode Island, Estados Unidos, 02915
- Bradley Hospital
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
13 años a 17 años (Niño)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- have attempted suicide prior to admission
- speak and read English fluently
- do not display evidence of significant cognitive impairment, based on a standard psychiatric exam as well as school records on admission
- are not actively psychotic at time of intake.
Exclusion Criteria:
- a significant general medical condition
- history of seizure, head injury, brain surgery or tumor
- intracranial metallic implants or implanted electrical devices
- substance abuse or dependence in the past six months.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Diagnóstico
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: anodal tDCS over the rIFG,
|
tDCS at a constant current of 1.5 milliampere (mA) will be applied for one 20-minute session over the right inferior frontal gyrus .
Resting-state EEG for 10 minutes will be recorded immediately prior to and after tDCS.
After post-tDCS resting state EEG is acquired, EEG is recorded to extract Evoked Response Potentials in a single-blind procedure.
The participants and assessors will be blind to experimental condition.
|
|
Experimental: anodal tDCS over the lOFC
|
tDCS at a constant current of 1.5 mA will be applied for one 20-minute session over the left orbitofrontal cortex .
Resting-state EEG for 10 minutes will be recorded immediately prior to and after tDCS.
After post-tDCS resting state EEG is acquired, EEG is recorded to extract Evoked Response Potentials in a single-blind procedure.
The participants and assessors will be blind to experimental condition.
|
|
Comparador de placebos: sham tDCS stimulation
|
In the sham condition, the current will be ramped up to 1.5 mA for 30 seconds and then ramped back down to 0. As this commonly used sham procedure produces a brief tingling sensation, participants are kept unaware of their experimental condition.
Resting-state EEG for 10 minutes will be recorded immediately prior to and after the sham tDCS.
After post-sham stimulation resting state EEG is acquired, EEG is recorded to extract Evoked Response Potentials in a single-blind procedure.
The participants and assessors will be blind to experimental condition.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Tarea de señal de parada (SST)
Periodo de tiempo: Dentro de una hora después de la condición de estimulación
|
La tarea de señal de parada (SST) es una tarea que requiere la inhibición de una respuesta motora prepotente.
El SST requiere que los participantes respondan a un estímulo objetivo de la manera más rápida y precisa posible presionando un botón, pero también que retengan su respuesta cuando escuchan una señal auditiva.
Por lo tanto, esta tarea implica una competencia entre los procesos de activación e inhibición.
La variable de resultado principal es el cambio en el tiempo de reacción de la señal de parada (SSRT) para la tarea administrada segundos a minutos antes y segundos a minutos después de la estimulación.
El mínimo teórico es cero segundos y no hay máximo teórico.
Las puntuaciones más altas de SSRT reflejan una mayor impulsividad.
|
Dentro de una hora después de la condición de estimulación
|
|
Delay Discounting Task
Periodo de tiempo: Within an hour post-stimulation condition
|
This task assessed discounting larger future rewards for smaller immediate ones.
The point where a person is equally likely to prefer immediate vs delayed reward (the indifference point) is determined for several and combinations of reward sizes and lengths of time.
Area under the curve (AUC) is calculated by summing the results of the following for each delay and indifference point pair: x2-x1[(y1 + y2)/2].
x1 and x2 are successive delays and y1 and y2 are indifference points for those delays.
AUC range=0-1.
Larger AUCs reflect less impulsivity.
|
Within an hour post-stimulation condition
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Richard Liu, PhD, Lifespan
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de abril de 2017
Finalización primaria (Actual)
31 de diciembre de 2019
Finalización del estudio (Actual)
31 de diciembre de 2019
Fechas de registro del estudio
Enviado por primera vez
2 de agosto de 2017
Primero enviado que cumplió con los criterios de control de calidad
5 de diciembre de 2017
Publicado por primera vez (Actual)
7 de diciembre de 2017
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
2 de febrero de 2022
Última actualización enviada que cumplió con los criterios de control de calidad
5 de enero de 2022
Última verificación
1 de enero de 2022
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- Liu 002017
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
SÍ
Descripción del plan IPD
Analysis files will be constructed from the stored electronic data and will be stripped of identifying information with the Safe Harbor method.
Specifically, youth and their parents will be identified with a family identifier and person identifier number that is randomly generated and not related to any element of their personal identifying information.
No names, addresses, telephone numbers, fax numbers, email addresses, social security numbers, medical records, etc. will be retained.
Dates will contain only year and a randomly generated day-of-the-year.
The investigators will only share it with external investigators when a data use agreement (DUA) is executed between Lifespan and the requester's institution.
The DUA will specify the requested data elements (each of which must be justified), the specific research question, the timeline for the project, and schedule for data destruction.
The data will be made available on April 1, 2021 by the PI
Marco de tiempo para compartir IPD
April 1, 2021
Criterios de acceso compartido de IPD
The investigators will only share it with external investigators when a data use agreement (DUA) is executed between the Brown University and the requester's institution.
The DUA will specify the requested data elements (each of which must be justified), the specific research question, the timeline for the project, and schedule for data destruction.
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- CIF
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Sí
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre anodal tDCS over the rIFG,
-
Riphah International UniversityTerminado
-
Jingchu HuInscripción por invitaciónDesórdenes de ansiedadPorcelana
-
University of New MexicoNational Institute of General Medical Sciences (NIGMS)ReclutamientoDesorden del espectro autista | Autismo o Rasgos AutistasEstados Unidos
-
University of Bernki:elementsReclutamientoEnvejecimiento | Voluntario Saludable | Trastorno Depresivo, Trastorno Depresivo MayorSuiza
-
IRCCS National Neurological Institute "C. Mondino...Fondazione Don Carlo Gnocchi Onlus; Istituti Clinici Scientifici Maugeri SpA; ASST... y otros colaboradoresTerminadoEnfermedad de Parkinson | Apoplejía, ComplicaciónItalia
-
Trustees of Dartmouth CollegeReclutamientoNo estamos estudiando una enfermedad o condiciónEstados Unidos
-
Sheffield Hallam UniversityDesconocidoModulación de la Flexibilidad Cognitiva por Estimulación de Corriente Directa Transcraneal, Administración de Tirosina y Polimorfismos en el Gen COMTReino Unido
-
Tan Tock Seng HospitalNg Teng Fong Healthcare Innovation ProgrammeReclutamiento
-
Istituto Ortopedico RizzoliTerminadoArtrosis, Rodilla | Desgarro del ligamento cruzado anteriorItalia
-
The University of Hong KongTerminado